Join us in Barcelona, Spain for an exclusive event on commercializing your diagnostic product in the US market from some of the leading experts in the industry:

 

• ​Market Access / reimbursement strategies, considerations, timelines, etc. (product medical policy / Medicare Local Coverage Determination / payor coverage)

​

• Coding (AMA CPT, PLA, MAAA, MolDX Z, WHO ICD-10 codes, etc.)

​

• Reimbursement (Clinical Lab Fee Schedule/CMS)

​

• FDA regulatory pathways, considerations, processes, and timelines

​

• Impact of recent legislative initiatives on the molecular diagnostic and medical device markets

​

• Commercial insurance / payor perspective on evidence development, addressing unmet needs, and processes in support of favorable medical policy coverage

​

• Business development, legal, and fund-raising considerations

​

• CLIA lab development in the US market (where to establish based on payor sources (e.g., MolDX / Medicare jurisdictions), tax implications, validation nuances and LDT vs. IVD considerations

​

• End of meeting panel discussion

 

​Please enter your contact information and we will keep you posted on the venue. We look forward to seeing you in Spain!